Reuters -- Drug maker Pfizer’s Venezuelan unit paid 36.59 million bolivars ($17 million) in back taxes after auditors questioned its transfer pricing methodology, Venezuela’s tax service said in a statement on Tuesday.
Reuters -- Drug maker Pfizer’s Venezuelan unit paid 36.59 million bolivars ($17 million) in back taxes after auditors questioned its transfer pricing methodology, Venezuela’s tax service said in a statement on Tuesday.
